BibTex RIS Cite

-

Year 2014, Volume: 6 Issue: 2, 47 - 54, 01.08.2014

Kutlu R Ruhuşen Kutlu Çivi S. Selma Çivi

https://doi.org/10.18521/ktd.37190
Cited By: 1

Abstract

Objective: Metabolic syndrome (MetS) is an endocrinopathic disorder defined by a cluster of abdominal obesity, dyslipidemia, high blood glucose level, and high blood pressure; the condition is recognized as a risk factor for diabetes mellitus and cardiovascular diseases. In this study, we aimed to assess the prevalence of MetS and related factors in adults. Method: This observational, cross-sectional analytic survey was conducted on 930 representative unselected people who applied with any problem to Family Medicine Outpatient Clinic. Of the participants, weight, height, waist circumference, blood pressure, fasting blood glucose level, total cholesterol, high density lipoprotein (HDL) and triglyceride levels were measured. MetS diagnosis was defined by the US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) guideline. Results: Of all the participants, 676 (72.7%) were female, 254 (27.3%) were male, the mean age was 52.64±12.16, 851 (91.5%) married, 238 (25.6%) illiterate, 319 (34.3%) primary school graduate, 556 (59.8%) were housewives. Of the total subjects, the overall frequency of MetS was 44.1% (49.0% in female, 31.2% in male). When we compared the results of MetS and gender, the frequency of MetS was higher 2.11 times among female (OR=2.110, 95% CI: 1.557-2.861), and this difference was statistically significant (p=0.001). Of the hypertensive individuals, 73.0% presented MetS. When we compared with the hypertensive and non-hypertensive individuals, the risk of MetS was higher 8.62 times among the hypertensive individuals (OR=8.622, 95% CI:6.39211.631), and statistically, this difference was significantly higher (p=0.001). Conclusion: MetS frequency was higher especially women in this study. Currently, this issue is also a crucial issue for our developing country like the other western developed countries. Resulting in chronic diseases, it is thought that the syndrome can be prevented by nutrition, physical activity and healthy lifestyle

Keywords

-

References

  • Grundy SM, Brewer HB Jr, Cleeman JI, et al. National Heart, Lung, and Blood Institute; AHA. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 2004;24(2):13-8.
  • Song KH, Yu SG, Kim JY. Prevalence of metabolic syndrome according to Sasang Constitutional Medicine in Korean subjects. Evid Based Complement Alternat Med 2012;2012:646794. Epub 2012 Feb 9.
  • Kozan O, Oguz A, Abaci A, et al. Prevalence of the metabolic syndrome among Turkish adults (METSAR). Eur J Clin Nutr 2007; 61:548-53.
  • Bloomgarden ZT. American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome:25-26 August 2002, Washington, DC. Diabetes Care 2003;26:1297-03.
  • Martínez MA, Puig JG, Mora M, et al. Metabolic syndrome: prevalence, associated factors, and C-reactive protein: the MADRIC (MADrid RIesgo Cardiovascular) Study. Metabolism 2008;57(9):1232-40.
  • Baker AR, Goodloe RJ, Larkin EK, et al. Multivariate association analysis of the components of metabolic syndrome from the Framingham Heart Study. BMC Proc 2009;3 Suppl 7:S42.
  • Misra A, Khurana L. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention. Metab Syndr Relat Disord 2009;7(6):497-14.
  • Hadaegh F, Zabetian A, Tohidi M, et al. Prevalence of metabolic syndrome by the Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions and their association with coronary heart disease in an elderly Iranian population. Ann Acad Med Singapore. 2009;38:142-9.
  • Aksakoğlu G. Correlation and regression computation methods In: Aksakoğlu G, eds. Sağlıkta araştırma ve çözümleme. 2. Baskı. İzmir: DEÜ Rektörlük Basımevi; 2006. p. 283-90.
  • National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
  • Bener A, Zirie M, Musallam M, et al. Prevalence of Metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation Criteria: A Population-Based Study. Meta Syndr Relat Disord 2009;7:221-29.
  • National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 1998;6(suppl 2): 51S–209S.
  • American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004;27:5–10.
  • Onat A, Ceyhan K, Basar O, et al. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels: prospective and cross-sectional evaluation. Atherosclerosis 2002;165:285-92.
  • Akbulut G. Does the Prevalence of metabolic syndrome in pre- and post-menopausal women differ by the ATP III and IDF Criteria? Turkiye Klinikleri J Med Sci 2011;31(6):1463-70.
  • Orhan H, Sadikoglu G, Ozcakir A, et al. Metabolic syndrome among women: A study from Bursa Turkey. TAF Prev Med Bull 2011;10(4):421-32.
  • Kitiş Y, Bilgili N, Hisar F, et al. Frequency and affecting factors of metabolic syndrome in women older than 20 years of age. Anadolu Kardiyol Derg 2010;10:111-9.
  • Oguz A, Sagun G, Uzunlulu M, et al. Sağlık çalışanlarında abdominal obezite ve metabolik sendrom sıklığı ve bu durumlar hakkında farkındalık düzeyleri. Arch Turk Soc Cardiol 2008; 36(5):302-309.
  • Varlıbaş F, Gencer M, Orken C, et al. Metabolic syndrome in cerebrovascular diseases. Journal of Neurological Science 2006;23 (2):93-101.
  • Baltalı M, Kızıltan HT, Korkmaz ME, et al. Koroner baypas sonrası hastalarda metabolik sendrom sıklığı ve tedaviye uyum oranları. Anadolu Kardiyol Derg 2004;4:10-16.
  • Katulanda P, Ranasinghe P, Jayawardana R, et al. Metabolic syndrome among Sri Lankan adults: prevalence, patterns and correlates. Diabetol Metab Syndr 2012;4(1):24.
  • Nanri A, Tomita K, Matsushita Y, et al. Effect of six months lifestyle intervention in Japanese men with metabolic syndrome: randomized controlled trial. J Occup Health 2012;54(3):215-22.
  • Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002;287:356-59.
  • Thomas GN, Ho SY, Janus ED, et al.; Hong Kong Cardiovascular Risk Factor Prevalence Study Steering Committee. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabetes Res Clin Pract 2005;67(3):251-7.
  • Beigh SH, Jain S. Prevalence of metabolic syndrome and gender differences. Bioinformation 2012;8(13):613-6. Epub 2012 Jul 6.
  • Miyatake N, Kawasaki Y, Nishikawa H, et al. Prevalence of metabolic syndrome in Okayama prefecture, Japan. Intern Med. 2006;45(2):107-8.
  • Dutra ES, Baiocchi de Carvalho KM, Miyazaki E, et al. Metabolic syndrome in central Brazil: prevalence and correlates in the adult population. Diabetol Metab Syndr 2012; 4: 20. Published online 2012 May 14. doi: 10.1186/1758-5996-4-20.
  • Mao X, Ait-Aissa K, Lagrange J, et al. Hypertension, hypercoagulability and the metabolic syndrome: a cluster of risk factors for cardiovascular disease. Biomed Mater Eng 2012;22(1-3):35-48.
  • Miyatake N, Wada J, Kawasaki Y, et al. Relationship between metabolic syndrome and cigarette smoking in the Japanese population. Intern Med 2006;45:1039-43.
  • McCoulay KM. Modifying women’s risk for cardiovascular disease. JOGNN 2007;36:116-24.
  • Chen CC, Li TC, Chang PC, et al. Association among cigarette smoking, metabolic syndrome, and its individual components: the metabolic syndrome study in Taiwan. Metabolism 2008;57(4):544-48. R, et 32. Masulli M, Riccardi G, Galasso al. the metabolic syndrome in a non-diabetic population. Nutr Metab Cardiovasc Dis 2006;16(5):364-70.
  • Relationship between smoking habits and the features of
  • Demir D, Bucaktepe EG, Kara İH. Metabolik sendrom, tip 2 diyabetes mellitus ve sağlıklı bireylerin sosyodemografik, antropometrik ve biyokimyasal özelliklerinin karşılaştırılması. Konuralp Tıp Dergisi [Konuralp Medical Journal] 2010;2(1):12-9.
  • Kara İH, Baltacı D, Sayın S, et al. Üreme çağındaki obez kadınlarda hematolojik ve biyokimyasal parametrelerin incelenmesi. Konuralp Tıp Dergisi [Konuralp Medical Journal] 2012;4(1):1-7.

Aile Hekimliği Polikliniğine Başvuran Yirmi Yaş ve Üzeri Erişkinlerde Metabolik Sendrom Sıklığı ve İlişkili Faktörler

Year 2014, Volume: 6 Issue: 2, 47 - 54, 01.08.2014

Kutlu R Ruhuşen Kutlu Çivi S. Selma Çivi

https://doi.org/10.18521/ktd.37190
Cited By: 1

Abstract

Amaç: Diyabetes mellitus ve kardivasküler hastalıklar için bir risk faktörü olarak bilinen metabolik sendrom (MetS) abdominal obezite, dislipidemi, yüksek kan glukoz seviyesi ve yüksek kan basıncı ile birlikte görülen bir endokrin bozukluktur. Bu çalışmada erişkinlerde MetS sıklığı ve ilişkili faktörlerin değerlendirilmesi amaçlanmıştır. Metod: Bu gözlemsel, kesitsel tipteki analitik araştırma aile hekimliği polikliniğine herhangi bir nedenle başvuran 930 kişide yapıldı. Katılımcıların ağırlık, boy, bel çevresi, kan basıncı, açlık kan şekeri, total kolesterol, HDL kolesterol ve trigliserit düzeyleri ölçüldü. MetS tanısı Ulusal Kolesterol Eğitim Programı Erişkin Tedavi Paneli III (NCEP ATP III) kılavuzuna göre konuldu. Bulgular: Çalışmaya katılan 930 kişinin 676’sı kadın (%72.7) 254’ü erkek (%27.3), yaş ortalaması 52.64±12.16 yaş, 851’i evli (%91.5), 238’i okuryazar değil (%25.6), 319’u (%34.3) ilköğretim eğitimli, 556’sı (%59.8) ev hanımı idi. Tüm katılanlarda MetS sıklığı %44.1 (kadınlarda %49.0, erkeklerde %31.2) idi. Kadınlarda MetS görülme sıklığı erkeklere göre 2.11 kat daha fazla bulundu (OR=2.110, %95 CI:1.5572.861), bu fark istatistiksel olarak önemli idi (p=0.001). Hipertansif olanların %73.0’ünde MetS tespit edildi. Hipertansif olanlarda MetS gelişme riski hipertansif olmayanlara göre 8.62 kat daha fazla idi (OR=8.622, %95 CI:6.392-11.631), bu fark istatistiksel olarak anlamlı derecede yüksekti (p=0.001). Sonuç: Çalışma grubumuzda MetS sıklığının kadınlarda daha fazla olmak üzere yüksek olduğu belirlenmiştir. Bu sorun gelişmesini tamamlamış batı ülkeleri kadar, halen gelişmekte olan ülkemiz için de ciddi bir sorundur. Bu sendrom doğru beslenme, fiziksel aktivite ve sağlıklı yaşam biçimi ile önlenebilir

Keywords

Metabolik Sendrom Erişkin Sıklık Risk Faktörleri

References

  • Grundy SM, Brewer HB Jr, Cleeman JI, et al. National Heart, Lung, and Blood Institute; AHA. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 2004;24(2):13-8.
  • Song KH, Yu SG, Kim JY. Prevalence of metabolic syndrome according to Sasang Constitutional Medicine in Korean subjects. Evid Based Complement Alternat Med 2012;2012:646794. Epub 2012 Feb 9.
  • Kozan O, Oguz A, Abaci A, et al. Prevalence of the metabolic syndrome among Turkish adults (METSAR). Eur J Clin Nutr 2007; 61:548-53.
  • Bloomgarden ZT. American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome:25-26 August 2002, Washington, DC. Diabetes Care 2003;26:1297-03.
  • Martínez MA, Puig JG, Mora M, et al. Metabolic syndrome: prevalence, associated factors, and C-reactive protein: the MADRIC (MADrid RIesgo Cardiovascular) Study. Metabolism 2008;57(9):1232-40.
  • Baker AR, Goodloe RJ, Larkin EK, et al. Multivariate association analysis of the components of metabolic syndrome from the Framingham Heart Study. BMC Proc 2009;3 Suppl 7:S42.
  • Misra A, Khurana L. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention. Metab Syndr Relat Disord 2009;7(6):497-14.
  • Hadaegh F, Zabetian A, Tohidi M, et al. Prevalence of metabolic syndrome by the Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions and their association with coronary heart disease in an elderly Iranian population. Ann Acad Med Singapore. 2009;38:142-9.
  • Aksakoğlu G. Correlation and regression computation methods In: Aksakoğlu G, eds. Sağlıkta araştırma ve çözümleme. 2. Baskı. İzmir: DEÜ Rektörlük Basımevi; 2006. p. 283-90.
  • National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
  • Bener A, Zirie M, Musallam M, et al. Prevalence of Metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation Criteria: A Population-Based Study. Meta Syndr Relat Disord 2009;7:221-29.
  • National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 1998;6(suppl 2): 51S–209S.
  • American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004;27:5–10.
  • Onat A, Ceyhan K, Basar O, et al. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels: prospective and cross-sectional evaluation. Atherosclerosis 2002;165:285-92.
  • Akbulut G. Does the Prevalence of metabolic syndrome in pre- and post-menopausal women differ by the ATP III and IDF Criteria? Turkiye Klinikleri J Med Sci 2011;31(6):1463-70.
  • Orhan H, Sadikoglu G, Ozcakir A, et al. Metabolic syndrome among women: A study from Bursa Turkey. TAF Prev Med Bull 2011;10(4):421-32.
  • Kitiş Y, Bilgili N, Hisar F, et al. Frequency and affecting factors of metabolic syndrome in women older than 20 years of age. Anadolu Kardiyol Derg 2010;10:111-9.
  • Oguz A, Sagun G, Uzunlulu M, et al. Sağlık çalışanlarında abdominal obezite ve metabolik sendrom sıklığı ve bu durumlar hakkında farkındalık düzeyleri. Arch Turk Soc Cardiol 2008; 36(5):302-309.
  • Varlıbaş F, Gencer M, Orken C, et al. Metabolic syndrome in cerebrovascular diseases. Journal of Neurological Science 2006;23 (2):93-101.
  • Baltalı M, Kızıltan HT, Korkmaz ME, et al. Koroner baypas sonrası hastalarda metabolik sendrom sıklığı ve tedaviye uyum oranları. Anadolu Kardiyol Derg 2004;4:10-16.
  • Katulanda P, Ranasinghe P, Jayawardana R, et al. Metabolic syndrome among Sri Lankan adults: prevalence, patterns and correlates. Diabetol Metab Syndr 2012;4(1):24.
  • Nanri A, Tomita K, Matsushita Y, et al. Effect of six months lifestyle intervention in Japanese men with metabolic syndrome: randomized controlled trial. J Occup Health 2012;54(3):215-22.
  • Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002;287:356-59.
  • Thomas GN, Ho SY, Janus ED, et al.; Hong Kong Cardiovascular Risk Factor Prevalence Study Steering Committee. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabetes Res Clin Pract 2005;67(3):251-7.
  • Beigh SH, Jain S. Prevalence of metabolic syndrome and gender differences. Bioinformation 2012;8(13):613-6. Epub 2012 Jul 6.
  • Miyatake N, Kawasaki Y, Nishikawa H, et al. Prevalence of metabolic syndrome in Okayama prefecture, Japan. Intern Med. 2006;45(2):107-8.
  • Dutra ES, Baiocchi de Carvalho KM, Miyazaki E, et al. Metabolic syndrome in central Brazil: prevalence and correlates in the adult population. Diabetol Metab Syndr 2012; 4: 20. Published online 2012 May 14. doi: 10.1186/1758-5996-4-20.
  • Mao X, Ait-Aissa K, Lagrange J, et al. Hypertension, hypercoagulability and the metabolic syndrome: a cluster of risk factors for cardiovascular disease. Biomed Mater Eng 2012;22(1-3):35-48.
  • Miyatake N, Wada J, Kawasaki Y, et al. Relationship between metabolic syndrome and cigarette smoking in the Japanese population. Intern Med 2006;45:1039-43.
  • McCoulay KM. Modifying women’s risk for cardiovascular disease. JOGNN 2007;36:116-24.
  • Chen CC, Li TC, Chang PC, et al. Association among cigarette smoking, metabolic syndrome, and its individual components: the metabolic syndrome study in Taiwan. Metabolism 2008;57(4):544-48. R, et 32. Masulli M, Riccardi G, Galasso al. the metabolic syndrome in a non-diabetic population. Nutr Metab Cardiovasc Dis 2006;16(5):364-70.
  • Relationship between smoking habits and the features of
  • Demir D, Bucaktepe EG, Kara İH. Metabolik sendrom, tip 2 diyabetes mellitus ve sağlıklı bireylerin sosyodemografik, antropometrik ve biyokimyasal özelliklerinin karşılaştırılması. Konuralp Tıp Dergisi [Konuralp Medical Journal] 2010;2(1):12-9.
  • Kara İH, Baltacı D, Sayın S, et al. Üreme çağındaki obez kadınlarda hematolojik ve biyokimyasal parametrelerin incelenmesi. Konuralp Tıp Dergisi [Konuralp Medical Journal] 2012;4(1):1-7.
There are 34 citations in total.

Details

Primary Language Turkish
Journal Section Articles
Authors

Kutlu R This is me

Ruhuşen Kutlu This is me

Çivi S. This is me

Selma Çivi This is me

Publication Date August 1, 2014
Published in Issue Year 2014 Volume: 6 Issue: 2

Cite

APA R, K., Kutlu, R., S., Ç., Çivi, S. (2014). Aile Hekimliği Polikliniğine Başvuran Yirmi Yaş ve Üzeri Erişkinlerde Metabolik Sendrom Sıklığı ve İlişkili Faktörler. Konuralp Medical Journal, 6(2), 47-54. https://doi.org/10.18521/ktd.37190
AMA R K, Kutlu R, S. Ç, Çivi S. Aile Hekimliği Polikliniğine Başvuran Yirmi Yaş ve Üzeri Erişkinlerde Metabolik Sendrom Sıklığı ve İlişkili Faktörler. Konuralp Medical Journal. August 2014;6(2):47-54. doi:10.18521/ktd.37190
Chicago R, Kutlu, Ruhuşen Kutlu, Çivi S., and Selma Çivi. “Aile Hekimliği Polikliniğine Başvuran Yirmi Yaş Ve Üzeri Erişkinlerde Metabolik Sendrom Sıklığı Ve İlişkili Faktörler”. Konuralp Medical Journal 6, no. 2 (August 2014): 47-54. https://doi.org/10.18521/ktd.37190.
EndNote R K, Kutlu R, S. Ç, Çivi S (August 1, 2014) Aile Hekimliği Polikliniğine Başvuran Yirmi Yaş ve Üzeri Erişkinlerde Metabolik Sendrom Sıklığı ve İlişkili Faktörler. Konuralp Medical Journal 6 2 47–54.
IEEE K. R, R. Kutlu, Ç. S., and S. Çivi, “Aile Hekimliği Polikliniğine Başvuran Yirmi Yaş ve Üzeri Erişkinlerde Metabolik Sendrom Sıklığı ve İlişkili Faktörler”, Konuralp Medical Journal, vol. 6, no. 2, pp. 47–54, 2014, doi: 10.18521/ktd.37190.
ISNAD R, Kutlu et al. “Aile Hekimliği Polikliniğine Başvuran Yirmi Yaş Ve Üzeri Erişkinlerde Metabolik Sendrom Sıklığı Ve İlişkili Faktörler”. Konuralp Medical Journal 6/2 (August 2014), 47-54. https://doi.org/10.18521/ktd.37190.
JAMA R K, Kutlu R, S. Ç, Çivi S. Aile Hekimliği Polikliniğine Başvuran Yirmi Yaş ve Üzeri Erişkinlerde Metabolik Sendrom Sıklığı ve İlişkili Faktörler. Konuralp Medical Journal. 2014;6:47–54.
MLA R, Kutlu et al. “Aile Hekimliği Polikliniğine Başvuran Yirmi Yaş Ve Üzeri Erişkinlerde Metabolik Sendrom Sıklığı Ve İlişkili Faktörler”. Konuralp Medical Journal, vol. 6, no. 2, 2014, pp. 47-54, doi:10.18521/ktd.37190.
Vancouver R K, Kutlu R, S. Ç, Çivi S. Aile Hekimliği Polikliniğine Başvuran Yirmi Yaş ve Üzeri Erişkinlerde Metabolik Sendrom Sıklığı ve İlişkili Faktörler. Konuralp Medical Journal. 2014;6(2):47-54.

Cited By

Tanı Almamış Tip 2 Diyabet İçin Bir Tarama Metodu Olarak Fin Diyabet Risk Anketi (FINDRISK) Uygulanabilir mi?
Konuralp Tıp Dergisi
Ruhuşen Kutlu
https://doi.org/10.18521/ktd.287466